Amryt has made a deal with Aegerion Pharmaceuticals, the NASDAQ-listed biopharmaceutical company, for the exclusive …
GlaxoSmithKline has announced today that both all endpoints were met in a pivotal phase III study of mepolizumab for rare disease
Erytech pulls off EU market application due to short time to get more data for CHMP
Sun Pharma with its subsidiaries agrees to buy 100% of Ocular Technologies
Faron Pharmaceuticals (Faron), the clinical stage biopharmaceutical company, has recruited the first patient in the Japanese Phase III pivotal clinical trial for the…
Teva Pharmaceutical has gotten a positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), recommending an indication extension of Trisenox (arsenic trioxide).
Bristol-Myers Squibb disappointed investors on Sunday as researchers detailed data for its Opdivo cancer immunotherapy, which was already known to have failed to do better than older chemotherapies in a closely watched clinical trial.